Analytics

How to interpret an HPLC chromatogram

9 min read Last updated March 10, 2026By PrimeGen Research TeamAdvanced

A practical reading guide for the chromatogram attached to a certificate of analysis: what retention time does and does not tell you, how integration and baseline placement change the reported figure, and which peak shapes indicate which impurity classes.

In summary

A practical reading guide for the chromatogram attached to a certificate of analysis: what retention time does and does not tell you, how integration and baseline placement change the reported figure, and which peak shapes indicate which impurity classes. This guide is published by PrimeGen Co., a United States supplier of lyophilized research peptides, and covers analytics for laboratory research contexts only.

Topic:
Analytics
Reading time:
9 min read
Sections:
What a chromatogram actually records · Retention time identifies nothing on its own · Reading peak shape · Integration and baseline placement · What to check before trusting a trace
Last updated:
March 10, 2026
Published by:
PrimeGen Co. research library
Scope:
Laboratory research use only — not medical guidance

Key takeaways

  • Retention time identifies nothing on its own; it is only meaningful against a reference run on the same method.
  • Shoulders and unresolved humps next to the main peak usually indicate closely related deletion or oxidised species.
  • Integration settings and baseline placement can move a reported purity figure by several tenths of a percent.

What a chromatogram actually records

A reversed-phase HPLC trace plots detector response — almost always UV absorbance at 214 or 220 nanometres, where the peptide bond itself absorbs — against elution time. Sample is injected onto a hydrophobic stationary phase and washed off with an increasing gradient of organic solvent. Compounds leave the column in order of hydrophobicity, and each produces a peak.

Purity is calculated from areas, not heights: the target peak area divided by the total integrated area of all peaks, expressed as a percentage. That definition carries two consequences. Anything that does not absorb at the detection wavelength is invisible to the calculation, and anything excluded from integration — for example a solvent front cut off at the start of the run — does not count against the result.

Retention time identifies nothing on its own

Retention time is a property of the method, not of the molecule. Change the gradient slope, the column chemistry, the column dimensions, the temperature or the flow rate and the same peptide elutes somewhere else. A retention time is only informative when compared against a reference standard run under identical conditions on the same instrument.

This is the single most common misreading of a certificate. A stated retention time confirms that the laboratory ran a method; it does not confirm identity. Identity comes from mass spectrometry, which is why a complete release package always pairs the two.

Reading peak shape

A well-behaved peak is narrow and close to symmetrical. Departures from that shape are diagnostic. A shoulder on the leading or trailing edge usually indicates a closely related species — most often a deletion sequence differing by one residue, or a diastereomer formed by racemisation during coupling. A broad, low, poorly resolved peak in a long or hydrophobic sequence commonly reflects on-column aggregation or conformational exchange rather than chemical impurity.

Tailing across all peaks, including any system peaks, points to a column or instrument issue rather than to the sample. Fronting typically indicates column overload — too much material injected — which also compresses apparent resolution and can inflate the reported purity by hiding small neighbours under a distorted main peak.

Small satellite peaks eluting just before the target are frequently more polar oxidation products; a peak sixteen daltons heavier on the corresponding mass spectrum confirms methionine oxidation. Late-eluting minor peaks are usually more hydrophobic adducts, often incompletely scavenged protecting-group fragments from cleavage.

Integration and baseline placement

Every reported purity figure embeds analyst or software decisions about where each peak begins and ends and where the baseline lies. Drawing the baseline across a rising background rather than under it, or setting a rejection threshold that discards small peaks, will shift a result by several tenths of a percent. None of this is misconduct — it is the ordinary discretion built into chromatographic integration — but it does mean purity figures should be read as measurements with a method-dependent uncertainty, not as exact constants.

In practice this makes within-laboratory, within-method comparisons far more meaningful than cross-vendor ones. Two laboratories reporting 98.6 and 99.1 percent for equivalent material are not necessarily disagreeing about the material.

What to check before trusting a trace

Confirm the sample identifier and lot number printed on the chromatogram match the vial and the certificate header. Check the method block states column, mobile phases, gradient, flow rate, wavelength and injection volume. Verify the run time is long enough that the gradient reached its end — a trace that stops early can leave late-eluting hydrophobic impurities uncounted. Look for a stable baseline before and after the peak of interest.

Finally, check the trace is an instrument output rather than a redrawn image. Genuine chromatograms carry axis labels, timestamps, integration marks and a peak table with retention times and area percentages. A smooth, unlabelled curve in a marketing PDF is an illustration, not analytical evidence.

Frequently asked questions

Can I compare purity figures from two different laboratories?
Only approximately. Detection wavelength, gradient, column chemistry, injection load and integration settings all influence the number. Differences of a few tenths of a percent between laboratories are usually methodological rather than material. Comparisons within one laboratory and one method are far more reliable.
Does a shoulder on the main peak mean the material is bad?
It means a closely related species is present and only partially resolved — commonly a deletion sequence or a diastereomer. Whether that matters depends on the study. The important point is that the certificate's purity figure already accounts for it if the integration captured it correctly.
Why is 214 nm used instead of 280 nm?
The peptide bond absorbs strongly near 214 nm, so every peptide is detectable regardless of sequence. Absorbance at 280 nm depends on aromatic residues — tryptophan, tyrosine and to a lesser extent phenylalanine — so peptides lacking them would be effectively invisible at that wavelength.

Related research compounds

Compounds covered by this article, each with its own monograph, specifications and lot-specific certificate of analysis.

About the author

PrimeGen Research Team

Analytical & technical writing, PrimeGen Co.

Our library is written in-house by the same team that reviews incoming lot analytics, reads third-party certificates of analysis and maintains compound documentation. Articles are educational reference material for laboratory professionals and describe published in vitro and preclinical literature only.

Published September 17, 2025 · Last reviewed March 10, 2026

References and further reading

  1. Reversed-phase HPLC of peptides: method development and interpretationPubMed, U.S. National Library of Medicine
  2. Chromatography general chapter and system suitabilityUnited States Pharmacopeia
  3. PubChem compound and substance databaseNational Center for Biotechnology Information

Where this fits in the Knowledge Center

Each hub sequences the guides, quality documentation and bench notes for a single topic, so you can move from this page into a structured reading path rather than a flat index.

Explore further

Move from this article into the catalog, the analytical documentation behind each lot, and the policies that govern every order.